FoodNourish Ingredients looks to tap Chinese market with Cabio...

Nourish Ingredients looks to tap Chinese market with Cabio partnership

-

spot_img


This audio is auto-generated. Please let us know if you have feedback.

Dive Brief:

  • Australian startup Nourish Ingredients announced a partnership with Chinese biotech company Cabio Biotech in order to scale its flagship product Tastilux, a plant-based ingredient that provides a meaty flavor, aroma and cooking experience to alternative proteins. 
  • Beyond plant-based meats, the companies said this partnership aims to capitalize on diverse market segments as their first cross-continental collaboration. Cabio will assist Nourish Ingredients by spearheading distribution and sales within the Chinese market, while Nourish leads commercial engagement and sales in other global markets, with Cabio providing manufacturing support.
  • “By leveraging Cabio’s established expertise, we’re not only derisking our supply chain for expansion but also enhancing our ability to deliver high-quality, innovative food solutions at scale,” Nourish Ingredients CEO James Petrie said in a statement.

Dive Insight:

Australian-based Nourish Ingredients creates its novel fat products via fermentation. Its Tastilux product is meant to bring an authentic taste and aroma to plant-based foods — from meat alternatives, prepared meals and snacks to spices and condiments.

Following its deal with Cabio, the ingredient will now be able to be produced at a commercial scale.

A key target market for Nourish Ingredients will be China’s burgeoning plant-based meat sector. 

China’s total meat consumption reaches nearly 100 million tons annually. Therefore, if Nourish turns just 1% of that market to plant-based alternatives by 2026, it would result in 1 million tons of plant-based meat.

Industry projections suggest the market for Chinese meat consumption could surge to a value of $3.5 billion by 2028, the company said.

The Tastilux product is produced by the same family of fungi that Cabio uses to produce the omega 6 fatty acid for infant formula, Petrie said, so the partnership is a strong fit.

Cabio manufacturing plants have a full set of capabilities such as bio-fermentation, non-solvent extraction, refining, winterization, and microencapsulation.

“This collaboration combines our cutting-edge product development with CABIO’s manufacturing excellence and market insights, positioning us to meet the surging global demand for superior food ingredients,” said Petrie. “Together, we’re set to efficiently produce top-tier products, opening doors to both the dynamic Chinese market and broader international opportunities.”



Source link

Latest news

Tottenham v Liverpool: Premier League – live | Premier League

Key eventsShow key events onlyPlease turn on JavaScript to use this featureLiverpool will be top at Christmas regardless...

Urinary tract infections are common in women, say doctors

Urinary tract infection is very common in women, with one in three having an episode before they turn...

From the Archives: Lisa Kudrow’s First “Xmas” Gone Awry

All her life she'd fantasized about a perfect Christmas celebration. When she finally tried to plan one, Lisa...

Sweden criticises China for refusing full access to vessel suspected of Baltic Sea cable sabotage

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly...
spot_img

We didn’t make it to the Paralympics, but we still have hope: the Gazan paracyclist | Gaza

Hazem Suleiman is a member of the Gaza Sunbirds, a paracycling team based in Gaza. A former footballer,...

Generating mutated proteins through adversarial attacks on the AlphaFold2 model

Announcing a new publication for Acta...

Must read

Tottenham v Liverpool: Premier League – live | Premier League

Key eventsShow key events onlyPlease turn on JavaScript...

Urinary tract infections are common in women, say doctors

Urinary tract infection is very common in women,...
spot_img

You might also likeRELATED
Recommended to you